Role and clinical course of verotoxigenic Escherichia coli infections in childhood acute diarrhoea in Argentina

Journal of Medical Microbiology

Volumn 59, Issue 3, 2010, Pages 345-352

  Rivero, Mariana Alejandra ^a   Passucci, Juan Antonio ^a   Rodriguez, Edgardo Mario ^a   Parma, Alberto Ernesto ^a  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; VEROTOXIN;

ACUTE DIARRHEA; ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLOOD; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DIARRHEA; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MONOLAYER CULTURE; MULTIPLEX POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; VERO CELL;

ANTI-BACTERIAL AGENTS; ARGENTINA; CHILD; CHILD, PRESCHOOL; DIARRHEA; DNA, BACTERIAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GENOTYPE; HUMANS; INCIDENCE; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SEROTYPING; SHIGA-TOXIGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

EID: 76649120190     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.015560-0     Document Type: Article

References (44)

1. Banatvala, N., Griffin, P. M., Greene, K. D., Barrett, T. J., Bibb, W. F., Green, J. H., Wells, J. G. & Hemolytic Uremic Syndrome Study Collaborators (2001). The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183, 1063-1070.
2. Bauer, A. W., Kirby, W. M. M., Sherris, J. C. & Turck, M. (1966). Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45, 493-496.
3. Beutin, L., Zimmermann, S. & Gleier, K. (1998). Human infections with Shiga toxin-producing Escherichia coli other than serogroup O157 in Germany. Emerg Infect Dis 4, 635-639.
4. Blanco, J., Blanco, M., Alonso, M. P., Blanco, J. E., Garabal, J. I. & González, E. A. (1992). Serogroups of Escherichia coli strains producing cytotoxic necrotizing factors CNF1 and CNF2. FEMS Microbiol Lett 75, 155-159.
5. Blanco, J. E., Blanco, M., Mora, A., Prado, C., Río, M., Fernández, L., Fernández, M. J., Saínz, V. & Blanco, J. (1996). Detection of enterohaemorrhagic Escherichia coli O157 :H7 in ground beef using immunomagnetic separation. Microbiologia 12, 385-394.
6. Blanco, M., Blanco, J. E., Blanco, J., Mora, A., Prado, C., Alonso, M. P., Mouriño, M., Madrid, C., Balsalobre, C. & other authors (1997). Distribution and characterization of fecal verotoxin-producing Escherichia coli (VTEC) isolated from healthy cattle. Comparison with VTEC obtained from calves with diarrhea. Vet Microbiol 54, 309-319.
7. Blanco, J. E., Blanco, M., Alonso, M. P., Mora, A., Dahbi, G., Coira, M. A. & Blanco, J. (2004). Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999. J Clin Microbiol 42, 311-319.
8. Chen, J. & Griffiths, M. W. (1998). PCR differentiation of Escherichia coli from other Gram-negative bacteria using primers derived from the nucleotide sequences flanking the gene encoding the universal stress protein. Lett Appl Microbiol 27, 369-371.
9. CLSI (2008). Performance Standards for Antimicrobial Susceptibility Testing, 18th Informational Supplement. M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute.
10. Conover, W. J. (1971). Practical Nonparametric Statistics. New York: Wiley.
11. Elliott, E. J., Robins-Browne, R.M., O'Loughlin, E. V., Bennett-Wood, V., Bourke, J., Henning, P., Hogg, G. G., Knight, J., Powell, H. & other authors (2001). Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 85, 125-131.
12. Espié, E., Grimont, F., Mariani-Kurkdjian, P., Bouvet, P., Haeghebaert, S., Filliol, I., Loirat, C., Decludt, B., Nhu Tran Minh, N. & other authors (2008). Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2000. Pediatr Infect Dis J 27, 595-601.
13. Gannon, V. P. J., Rashed, M., King, R. K. & Golsteyn Thomas, E. J. (1993). Detection and characterization of the eae gene of Shiga-like toxin-producing Escherichia coli using polymerase chain reaction. J Clin Microbiol 31, 1268-1274.
14. Gerber, A., Karch, H., Allerberg, F., Verweyen, M. & Zimmerhackl, L. B. (2002). Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 186, 493-500.
15. Giugno, S. M., Bibiloni, N., Rahman, R., Miliwebsky, E., Chinen, I. & Rivas, M. (2007). Association between uremic hemolytic syndrome and infection by Shiga toxin-producing Escherichia coli. Acta Bioquím Clín Latinoam 41, 27-33 (in Spanish).
16. Goldwater, P. N. (2007). Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome. Expert Rev Anti Infect Ther 5, 653-663.
17. Goldwater, P. N. & Bettelheim, K. A. (1998). New perspectives on the role of Escherichia coli O157 :H7 and other enterohaemorrhagic E. coli serotypes in human disease. J Med Microbiol 47, 1039-1045.
18. Griffin, P. M. & Tauxe, R. V. (1991). The epidemiology of infections caused by Escherichia coli O157 : H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 13, 60-98.
19. Johnson, K. E., Thorpe, C. M. & Sears, C. L. (2006). The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis 43, 1587-1595.
20. Karch, H., Tarr, P. I. & Bielaszewska, M. (2005). Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 295, 405-418.
21. Karmali, M. A. (1989). Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 2, 15-38.
22. Klein, E. J., Stapp, J. R., Clausen, C. R., Boster, D. R.,Wells, J. G., Qin, X., Swerdlow, D. L. & Tarr, P. I. (2002). Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 141, 172-177.
23. Kru&dieger, A., Padola, N. L., Parma, A. E. & Lucchesi, P. M. A. (2006). Intraserotype diversity among Argentinian verocytotoxigenic Escherichia coli detected by random amplified polymorphic DNA analysis. J Med Microbiol 55, 545-549.
24. Lindqvist, R., Antonsson, A. K., Norling, B., Persson, L., Ekstro&diem, C. L., Fa&dieger, U., Eriksson, E., Lofdahl, S. & Norberg, P. (1998). The prevalence of verocytotoxin-producing Escherichia coli (VTEC) and E. coli O157 :H7 in beef in Sweden determined by PCR assays and an immuno-magnetic separation (IMS) method. Food Microbiol 15, 591-601.
25. López, E. L., Contrini, M. M. & De Rosa, M. F. (1998). Epidemiology of Shiga toxin-producing E. coli in South America. In Escherichia coli O157 : H7 and Other Shiga Toxin-Producing E. coli Strains, pp. 30-37. Edited by J. B. Kaper & A. D. O'Brien. Washington, DC: American Society for Microbiology.
26. Orskov, F. & Orskov, I. (1984). Serotyping of Escherichia coli. Methods Microbiol 114, 43-112.
27. Oshima, T. (1997). Predictive factors for development of hemolytic uremic syndrome (HUS) and early intensive treatments for prevention of HUS enterohemorrhagic Escherichia coli infection. Jpn J Antibiot 50, 855-861.
28. Padola, N. L., Sanz, M. E., Blanco, J. E., Blanco, M., Blanco, J., Etcheverría, A. I., Arroyo, G. H., Usera, M. A. & Parma, A. E. (2004). Serotypes and virulence genes of Shigatoxigenic Escherichia coli (STEC) isolated from a feedlot in Argentina. Vet Microbiol 100, 3-9.
29. 2, eae, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J Clin Microbiol 36, 598-602.
30. 2, eae, ehxA, and saa. J Clin Microbiol 40, 271-274.
31. Paton, A.W., Ratcliff, R. M., Doyle, R.M., Seymour-Murray, J., Davos, D., Lanser, J. A. & Paton, J. C. (1996). Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli. J Clin Microbiol 34, 1622-1627.
32. Paton, A. W., Srimanote, P., Woodrow, M. C. & Paton, J. C. (2001). Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect Immun 69, 6999-7009.
33. Piérard, D., Stevens, D., Moriau, L., Lior, H. & Lauwers, S. (1997). Isolation and virulence factors of verocytotoxin-producing Escherichia coli in human stool samples. Clin Microbiol Infect 3, 531-540.
34. Pradel, N., Livrelli, V., De Champs, C., Palcoux, J.-B., Reynaud, A., Scheutz, F., Sirot, J., Joly, B. & Forestier, C. (2000). Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food and children during a one-year prospective study in France. J Clin Microbiol 38, 1023-1031.
35. Proulx, F., Seidman, E. G. & Karpman, D. K. (2001). Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res 50, 163-171.
36. Rivas, M., Miliwebsky, E., Chinen, I., Deza, N. & Leotta, G. A. (2006). The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission. Medicina (B Aires) 66 (Suppl. 3), 27-32 (in Spanish).
37. Rivas, M., Sosa-Estani, S., Rangel, J., Caletti, M. G., Vallés, P., Roldán, C. D., Balbi, L., Marsano de Mollar, M. C., Amoedo, D. & other authors (2008). Risk factors for sporadic Shiga toxin-producing Escherichia coli infections in children, Argentina. Emerg Infect Dis 14, 763-771.
38. Rivero, M. A., Padola, N. L., Etcheverría, A. I. & Parma, A. E. (2004). Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome in Argentina. Medicina (B Aires) 64, 352-356 (in Spanish).
39. Sanz, M. E., Viñas, M. R. & Parma, A. E. (1998). Prevalence of bovine verotoxin-producing Escherichia coli in Argentina. Eur J Epidemiol 14, 399-403.
40. Slutsker, L., Ries, A. A., Greene, K. D., Wells, J. G., Hutwagner, L. & Griffin, P. (1997). Escherichia coli O157 :H7 diarrhea in the United States: clinical and epidemiological features. Ann Intern Med 126, 505-513.
41. Tarr, P. I., Gordon, C. A. & Chandler, W. L. (2005). Shiga-toxinproducing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073-1086.
42. Voyer, L. E. (1996). Síndrome Urémico Hemolítico. Buenos Aires: Ed. López.
43. Willshaw, G. A., Cheasty, T., Smith, H. R., O'Brien, S. J. & Adak, G. K. (2001). Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995-1998. J Med Microbiol 50, 135-142.
44. Wong, C. S., Jelacic, S., Habeeb, R. L., Watkins, S. L. & Tarr, P. I. (2000). The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157 :H7 infections. N Engl J Med 342, 1930-1936.